Bildkälla: Stockfoto

Vicore Pharma: Our Comment on C21 Follow-Up Data in Covid-19 - Redeye

Redeye comments on the follow-up data from Vicore’s Phase II Covid-19 trial and give our first take.

Redeye comments on the follow-up data from Vicore’s Phase II Covid-19 trial and give our first take.
Börsvärldens nyhetsbrev
ANNONSER